VTR (Ventas) Valuation Rank


VTR Ventas Inc VTR
79 GF Score
Price $89.40
GF Value $69.98
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ventas Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ventas Valuation Rank Related Terms

VTR
79GF Score
Ventas Inc VTR
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ventas (VTR) Overvalued in 2026?

Based on GuruFocus' analysis, Ventas stock appears to be overvalued. The current stock price of $89.40 is trading 27.8% above its estimated GF Value™ of $69.98. GuruFocus considers Ventas to be Modestly Overvalued.

Key valuation signals for VTR:

  • Valuation Rank:
  • GF Value™: $69.98 vs. price of $89.40 (27.8% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the VTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ventas Business Description

Industry Real EstateREITs
Address 300 North LaSalle Street, Suite 1600, Chicago, IL, USA, 60654
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
79GF Score

Get the complete analysis for VTR

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.40
Price
$69.98
GF Value